有価証券レコード · アーカイブ済み四半期
MLAB
Mesa Laboratories, Inc. · Healthcare · Medical - Specialties
17追跡対象保有者
+1Δ保有者数
1.54M保有株数
$103.48M報告済み評価額
+2新規ポジション
−1解消銘柄
モメンタム指標（同類マネージャー）：
保有者の広がり +6.2% ·
株式フロー -24.3% ·
新規ネットポジション数 +5.9%
— 計算式
保有の分散化 — 保有者数の増加、合計持分の縮小
すべての保有状況データ：追跡対象13Fマネージャーのみ、普通株ポジション、報告期間 Q3 2025
保有状況の推移
| 四半期 | 保有者 | Δ | 株数 | 報告済み評価額 | 新規 | 解消銘柄 |
|---|---|---|---|---|---|---|
| Q2 2026 | 67 | 0 | 2.99M | $297.50M | +4 | −4 |
| Q1 2026 | 70 | 0 | 2.66M | $235.21M | +6 | −6 |
| Q4 2025 | 70 | +2 | 2.73M | $214.06M | +2 | — |
| Q3 2025 | 17 | +1 | 1.54M | $103.48M | +2 | −1 |
| Q2 2025 | 13 | +4 | 1.73M | $163.31M | +4 | — |
| Q1 2025 | 6 | -3 | 383.09K | $45.46M | — | −3 |
| Q4 2024 | 9 | +1 | 400.64K | $52.84M | +1 | — |
| Q3 2024 | 7 | 0 | 174.94K | $22.72M | +1 | −1 |
| Q2 2024 | 7 | — | 189.52K | $16.45M | — | — |
保有者情報 · Q3 2025
| # | 運用会社 | 株数 | Δ株式数 | 時価 | そのウェイト | 保有中 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (パッシブ) | 388.80K | -50.9% | $26.05M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | BlackRock ✦ (パッシブ) | 388.80K | -50.9% | $26.05M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | BlackRock ✦ (パッシブ) | 388.80K | -50.9% | $26.05M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | BlackRock ✦ (パッシブ) | 388.80K | -50.9% | $26.05M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | BlackRock ✦ (パッシブ) | 388.80K | -50.9% | $26.05M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | BlackRock ✦ (パッシブ) | 388.80K | -50.9% | $26.05M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | BlackRock ✦ (パッシブ) | 388.80K | -50.9% | $26.05M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | BlackRock ✦ (パッシブ) | 388.80K | -50.9% | $26.05M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | BlackRock ✦ (パッシブ) | 388.80K | -50.9% | $26.05M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | BlackRock ✦ (パッシブ) | 388.80K | -50.9% | $26.05M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | The Vanguard Group ✦ (パッシブ) | 321.72K | -17.4% | $21.56M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | The Vanguard Group ✦ (パッシブ) | 321.72K | -17.4% | $21.56M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | The Vanguard Group ✦ (パッシブ) | 321.72K | -17.4% | $21.56M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | Morgan Stanley ✦ | 254.97K | — | $17.09M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Morgan Stanley ✦ | 254.97K | — | $17.09M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Morgan Stanley ✦ | 254.97K | — | $17.09M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Morgan Stanley ✦ | 254.97K | — | $17.09M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Morgan Stanley ✦ | 254.97K | — | $17.09M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Morgan Stanley ✦ | 254.97K | — | $17.09M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | Morgan Stanley ✦ | 254.97K | — | $17.09M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Morgan Stanley ✦ | 254.97K | — | $17.09M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Morgan Stanley ✦ | 254.97K | — | $17.09M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Millennium Management ✦ | 133.82K | +131.9% | $8.97M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 24 | Geode Capital Management ✦ (パッシブ) | 127.86K | -7.9% | $8.57M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 25 | Geode Capital Management ✦ (パッシブ) | 127.86K | -7.9% | $8.57M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 26 | State Street Global Advisors ✦ (パッシブ) | 118.95K | -43.9% | $7.97M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 27 | Goldman Sachs Group ✦ | 41.78K | — | $2.80M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Goldman Sachs Group ✦ | 41.78K | — | $2.80M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | Citadel Advisors ✦ | 34.18K | +27.2% | $2.29M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 30 | Citadel Advisors ✦ | 34.18K | +27.2% | $2.29M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 31 | D. E. Shaw & Co. ✦ | 32.81K | +278.7% | $2.20M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 32 | AQR Capital Management ✦ | 32.64K | +322.4% | $2.19M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 33 | AQR Capital Management ✦ | 32.64K | +322.4% | $2.19M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 34 | AQR Capital Management ✦ | 32.64K | +322.4% | $2.19M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 35 | AQR Capital Management ✦ | 32.64K | +322.4% | $2.19M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 36 | AQR Capital Management ✦ | 32.64K | +322.4% | $2.19M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 37 | Marshall Wace ✦ | 14.60K | 新規 | $978,346 | 0.0% | New | 1 | SEC ↗ |
| 38 | Marshall Wace ✦ | 14.60K | 新規 | $978,346 | 0.0% | New | 1 | SEC ↗ |
| 39 | Marshall Wace ✦ | 14.60K | 新規 | $978,346 | 0.0% | New | 1 | SEC ↗ |
| 40 | Renaissance Technologies ✦ | 10.90K | -84.0% | $730,409 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 41 | Two Sigma Investments ✦ | 9.62K | 新規 | $644,837 | 0.0% | New | 1 | SEC ↗ |
| 42 | JPMorgan Chase ✦ | 8.64K | — | $579,100 | 0.0% | n/c | 1 | SEC ↗ |
| 43 | JPMorgan Chase ✦ | 8.64K | — | $579,100 | 0.0% | n/c | 1 | SEC ↗ |
| 44 | JPMorgan Chase ✦ | 8.64K | — | $579,100 | 0.0% | n/c | 1 | SEC ↗ |
| 45 | JPMorgan Chase ✦ | 8.64K | — | $579,100 | 0.0% | n/c | 1 | SEC ↗ |
| 46 | JPMorgan Chase ✦ | 8.64K | — | $579,100 | 0.0% | n/c | 1 | SEC ↗ |
| 47 | JPMorgan Chase ✦ | 8.64K | — | $579,100 | 0.0% | n/c | 1 | SEC ↗ |
| 48 | JPMorgan Chase ✦ | 8.64K | — | $579,100 | 0.0% | n/c | 1 | SEC ↗ |
| 49 | JPMorgan Chase ✦ | 8.64K | — | $579,100 | 0.0% | n/c | 1 | SEC ↗ |
| 50 | JPMorgan Chase ✦ | 8.64K | — | $579,100 | 0.0% | n/c | 1 | SEC ↗ |
| 51 | JPMorgan Chase ✦ | 8.64K | — | $579,100 | 0.0% | n/c | 1 | SEC ↗ |
| 52 | GAMCO Investors ✦ | 8.21K | +109.0% | $550,286 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 53 | T. Rowe Price ✦ | 4.11K | +7.4% | $276,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 54 | Fidelity (FMR) ✦ | 606 | -79.3% | $40,608 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 55 | Fidelity (FMR) ✦ | 606 | -79.3% | $40,608 | 0.0% | ▼ Trim | 2 | SEC ↗ |
「当該ウェイト」= そのマネージャーの報告済み13F株式評価額に占めるポジションの割合（確信度の指標）。✦ = キュレーション済みマネージャー。
新規買い手
| Marshall Wace | $978,346 | 0.0% |
| Marshall Wace | $978,346 | 0.0% |
| Marshall Wace | $978,346 | 0.0% |
| Two Sigma Investments | $644,837 | 0.0% |
ポジション解消済み
| Wellington Management | $2.12M | だった 0.0% |
市場全体のコンテキスト: 全13Fファイラー対象（SEC構造化データ、 Q1 2026): 158 保有者, 4.82M 株式数, $424.86M 報告済み. これは上記の追跡対象ユニバースの数値とは異なる、より古い期間のものであり、両者が混在することはありません。
共同保有が多い銘柄
この有価証券の追跡対象保有者が最も頻繁に保有する他の銘柄 — ファンダメンタルな関係ではなく、共同保有件数に基づきます。
市場内買い付け (P)
Aug 13
Kadia Siddhartha
Officer · President and CEO · 7.09K 株 @ 112.80 · $800,090
Aug 13
Tripeny R Tony
Director · 900 株 @ 113.69 · $102,321
市場内売却 (S)
Aug 13
Sullivan John James
Director · 7.09K 株 · $800,090
株式付与、権利行使および税務目的の株式差し引きは、買いや売りとして集計しません。 方法論
Jul 07
SC 13G/A — Long Path Smaller Companies Fund, LP